Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00909428 · ClinicalTrials.gov registry record · Phase 4

Validation of a Real-time Urodynamic Measure of Urinary Urgency

A Phase 4 study, sponsored by Loyola University.

Completed
Registry status
Phase 4
Development phase
51
Enrollment target

NCT00909428 is a Phase 4 study that has completed, run by Loyola University. The registered enrollment target is 51 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00909428, a Phase 4 study, has completed, sponsored by Loyola University.

COMPLETED
Registry status
Phase 4
Development phase
51 participants
Enrollment target

Study Summary

Urinary urgency is a key symptom of overactive bladder syndrome (OAB) and may be more bothersome to a patient than the symptom of urinary frequency. Unfortunately, controversy continues to surround the term 'urgency' and there is no good tool to evaluate the severity of urgency. This fact has constrained the performance of clinical research in this field. The cause of urinary urgency is not fully understood and may vary from patient to patient. Although clinicians regularly obtain measures of bladder sensation during cystometry, little attention has been paid to the patient experience of urinary urgency. In this study, the researchers will use a non-significant risk device (i.e., an Urgeometer) to measure urinary urgency in women with overactive bladder.

Interventions

  • DRUG Solifenacin Succinate

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2007-01
Est. Completion 2009-02
Phase Phase 4

Sponsor

Loyola University

92 total trials

What the Registry Record Tells You About NCT00909428

The ClinicalTrials.gov registry entry for NCT00909428 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Solifenacin Succinate is the first listed.

NCT00909428 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00909428 about?

NCT00909428 is a clinical study titled "Validation of a Real-time Urodynamic Measure of Urinary Urgency". Urinary urgency is a key symptom of overactive bladder syndrome (OAB) and may be more bothersome to a patient than the symptom of urinary frequency. Unfortunately, controversy continues to surround the term 'urgency' and there is no good tool to evaluate the severity of urgency. This fact has constr...

What is the current status of trial NCT00909428?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 51 participants. The study started on 2007-01. Estimated completion is 2009-02.

What interventions are being tested in trial NCT00909428?

The interventions under investigation include: Solifenacin Succinate (DRUG).

Who is sponsoring clinical trial NCT00909428?

This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.